Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
C4x Discovery Holdings plc

Start price
Target price
Perf. (%)
€0.49
02.12.21
-
02.12.22
-53.06%
03.12.22

Could be worthwhile Investment >10% per year
buy
E-Therapeutics Plc

Start price
Target price
Perf. (%)
€0.49
02.12.21
-
02.12.22
-48.98%
03.12.22

Could be worthwhile Investment >10% per year
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€1.43
01.12.21
-
01.12.22
20.66%
12.12.21

Risky Investment
buy
Lannett Co. Inc.

Start price
Target price
Perf. (%)
€5.88
01.12.21
-
01.12.22
-61.58%
02.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€14.52
01.12.21
-
01.12.22
-11.23%
11.12.21

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
buy
Invitae Corp

Start price
Target price
Perf. (%)
€15.29
01.12.21
€20.00
31.12.23
-90.75%
08.05.23

Could be very worthwhile Investment >20% year
Krystal Biotech

Start price
Target price
Perf. (%)
€66.00
01.12.21
€50.00
31.12.23
16.67%
08.05.23

Could be very worthwhile Investment >20% year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€23.38
30.11.21
€25.00
30.11.22
-71.89%
07.07.22

Could be worthwhile Investment >10% per year
Innovative
Few uniques
buy
Valneva SE

Start price
Target price
Perf. (%)
€29.96
30.11.21
€35.00
30.11.22
-66.46%
12.08.22

Could be very worthwhile Investment >20% year
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€49.00
29.11.21
-
29.11.22
29.80%
30.11.22

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€41.50
29.11.21
-
29.11.25
-56.01%
21.03.23

Could be very worthwhile Investment >20% year
Krystal Biotech

Start price
Target price
Perf. (%)
€77.00
29.11.21
-
29.11.22
-19.48%
10.12.21

Probably not worthwhile Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€9.94
29.11.21
-
29.11.25
-83.35%
11.03.24

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.32
29.11.21
-
29.11.22
-65.32%
21.07.22

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.03
29.11.21
-
29.11.22
-21.12%
30.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€2.64
28.11.21
-
28.11.22
-77.46%
29.11.22

Risky Investment
buy
Futura Medical

Start price
Target price
Perf. (%)
€0.36
27.11.21
€0.50
27.11.22
30.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.24
27.11.21
€8.00
27.11.22
-47.90%
28.11.22

Could be worthwhile Investment >10% per year